Inpatient Level of Care for Ophthalmic Segment Aneurysm Treatment

Rationale for Medical Necessity

The American Heart Association recognizes that advances in intravascular stent technology have broadened indications for endovascular treatment of cerebral aneurysms, particularly for wide-necked or complex morphology lesions, which is applicable to this 60-year-old male patient with a 4mm ophthalmic segment aneurysm 1, 4.
The patient's age of 60 years represents a population where treatment benefits outweigh observation risks, as he has sufficient life expectancy to benefit from rupture prevention, according to guidelines from the American Heart Association 2, 3.

The American Heart Association explicitly states that endovascular coil embolization and stent-assisted techniques are appropriate for intracranial aneurysms, with selection based on aneurysm characteristics, patient factors, and institutional expertise, which supports the use of pipeline stent for this patient's ophthalmic segment aneurysm 1, 2, 3.
Internal carotid artery aneurysms (which include ophthalmic segment lesions) are recognized as "difficult to treat with surgery but may be treated relatively easily with coil embolization" and stent-assisted techniques, according to the American Heart Association 2, 5, 6.

Unruptured aneurysms with irregular morphology carry significantly elevated rupture risk compared to smooth-walled lesions, which justifies prophylactic treatment for this patient's aneurysm 2, 3.
Early definitive treatment with pipeline stent prevents the catastrophic morbidity and mortality associated with aneurysmal subarachnoid hemorrhage, with a high complete obliteration rate and acceptable morbidity 2, 3.